XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders Equity (Tables)
9 Months Ended
Sep. 30, 2017
Stock-Based Compensation Expense

Stock-based compensation expense was classified on the statement of operations as follows for the three and nine months ended September 30, 2017 and 2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

 

 

    

2017

 

2016

   

2017

 

2016

    

Research and development expense

 

$

327,133

 

$

260,882

 

$

953,821

 

$

772,163

 

General and administrative expense

 

 

635,212

 

 

478,531

 

 

1,842,480

 

 

1,466,484

 

Total stock-based compensation expense

 

$

962,345

 

$

739,413

 

$

2,796,301

 

$

2,238,647

 

 

2003 Stock Incentive Plan  
Company's Stock Option Activity

A summary of the Company’s stock option activity under the 2003 Plan for the nine months ended September 30, 2017 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

Outstanding

 

Weighted-Average

 

Contractual Term

 

Intrinsic Value

 

 

    

Options

    

Exercise Price

    

(Years)

    

(In thousands)

 

Outstanding as of December 31, 2016

 

729,819

 

$

1.26

 

3.2

 

 

 

 

Options exercised

 

(16,608)

 

 

1.65

 

 

 

 

 

 

Options forfeited

 

 —

 

 

 —

 

 

 

 

 

 

Outstanding as of September 30, 2017

 

713,211

 

 

1.25

 

2.4

 

$

9,089

 

Vested as of September 30, 2017

 

713,211

 

 

1.25

 

2.4

 

$

9,089

 

Exercisable as of September 30, 2017

 

713,211

 

 

1.25

 

2.4

 

$

9,089

 

 

2013 Equity Incentive Plan  
Company's Stock Option Activity

A summary of the Company’s stock option activity under the 2013 Plan for the nine months ended September 30, 2017 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

Outstanding

 

Weighted-Average

 

Contractual Term

 

Intrinsic Value

 

 

 

Options

    

Exercise Price

    

(Years)

    

(In thousands)

 

Outstanding as of December 31, 2016

 

2,066,105

 

$

7.41

 

7.9

 

 

 

 

Options granted

 

674,738

 

 

7.03

 

 

 

 

 

 

Options exercised

 

(32,521)

 

 

5.96

 

 

 

 

 

 

Options forfeited

 

(22,159)

 

 

7.35

 

 

 

 

 

 

Outstanding as of September 30, 2017

 

2,686,163

 

 

7.33

 

7.6

 

$

17,884

 

Vested or expected to vest as of September 30, 2017

 

2,686,163

 

 

7.33

 

7.6

 

$

17,884

 

Exercisable as of September 30, 2017

 

1,453,937

 

 

7.84

 

6.7

 

$

9,003

 

 

Weighted-Average Fair Value of Options Granted

 

 

 

 

 

 

 

 

Nine Months Ended

 

Nine Months Ended

 

    

September 30, 2017

 

September 30, 2016

Expected term

 

6.25 years

 

6.25 years

Expected volatility

 

75.20%

 

68.86%

Risk-free interest rate

 

2.08%

 

1.69%

Expected dividend yield

 

0%

 

0%

 

Summary of RSU Activity

The following is a summary of RSU activity under the 2013 Plan for the nine months ended September 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

Number

 

Grant Date

 

 

    

of Shares

 

 

Fair Value

 

Unvested at December 31, 2016

 

 

16,916

 

$

5.04

 

Granted

 

 

 —

 

 

 —

 

Forfeited

 

 

 —

 

 

 —

 

Vested

 

 

4,833

 

 

4.61

 

Unvested at September 30, 2017

 

 

12,083

 

 

5.21